PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy Via Enhanced Viral Mimicry
Amish J. Patel,Sarah Warda,Jesper L. Maag,Rohan Misra,Miguel A. Miranda-Roman,Mohini R. Pachai,Cindy J. Lee,Dan Li,Naitao Wang,Gabriella Bayshtok,Eve Fishinevich,Yinuo Meng,Elissa W. P. Wong,Juan Yan,Emily Giff,Melissa B. Pappalardi,Michael T. McCabe,Jonathan A. Fletcher,Charles M. Rudin,Sarat Chandarlapaty,Joseph M. Scandura,Richard P. Koche,Jacob L. Glass,Cristina R. Antonescu,Deyou Zheng,Yu Chen,Ping Chi crossref（2023）
摘要
Supplementary Data from PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry
更多查看译文
关键词
mRNA modification,PRMT1
AI 理解论文
溯源树
样例
